Advertisement
Pharmaceuticals and Biotech
Subscribe to Pharmaceuticals and Biotech

The Lead

U.S. To Begin Safety Testing Ebola Vaccine Next Week

August 28, 2014 11:31 am | by Seth Borenstein - AP Science Writer - Associated Press | News | Comments

Federal researchers next week will start testing humans with an experimental vaccine to prevent the deadly Ebola virus. The National Institutes of Health announced Thursday that it is launching the safety trial on a vaccine developed by ... 

Allergan Reviews Meeting Requests In Takeover Bid

August 25, 2014 1:04 pm | by Linda A. Johnson, AP Business Writer | News | Comments

Botox maker Allergan Inc. is reviewing shareholder requests for a special meeting to consider...

Roche To Buy U.S. Biotech Firm InterMune For $8.3B

August 25, 2014 10:05 am | by The Associated Press | News | Comments

Swiss pharmaceutical company Roche said Sunday it has reached an $8.3 billion deal to buy...

Animal Health Company To Open Plant In St. Joseph

August 21, 2014 7:30 am | by The Associated Press | News | Comments

A company that handles animal medicines plans to open a missive new warehouse and packaging...

View Sample

FREE Email Newsletter

Daily news and top headlines for manufacturing professionals

Execution Drug Cost Quadruples For Texas Prisons

August 19, 2014 11:06 am | by Michael Graczyk, Associated Press | News | Comments

Texas is paying four times more for its execution drugs from a new supplier, putting it in line with a local consumer rate but well below the cost in at least one other death penalty state. The prison agency in the nation's busiest death penalty state paid ...

Scientists Racing To Test Ebola Vaccines In Humans

August 14, 2014 6:28 pm | by Matthew Perrone - Associated Press | News | Comments

Scientists are racing to begin the first human safety tests of two experimental Ebola vaccines, but it won't be easy to prove that the shots and other potential treatments in the pipeline really work. There are no proven drugs or vaccines for Ebola, a disease so rare that ...

Rooting Out Skin Creams That Contain Toxic Mercury

August 13, 2014 11:48 am | by Michael Bernstein, American Chemical Society | News | Comments

As countries try to rid themselves of toxic mercury pollution, some people are slathering and even injecting creams containing the metal onto or under their skin to lighten it, putting themselves and others at risk for serious health problems. To find those most ...

Advertisement

FDA Lifts Hold On Experimental Ebola Drug

August 8, 2014 8:15 am | by Matthew Perrone, AP Health Writer | News | Comments

U.S. health authorities have eased safety restrictions on an experimental drug to treat Ebola, a move that could clear the way for its use in patients infected with the deadly virus.                     

British-U.S. Investigative Couple On Trial In China

August 8, 2014 8:12 am | News | Comments

A Briton and an American charged with illegally trading in the personal details of Chinese nationals testified Friday that they bought such information to help companies combat fraud.               

Pfizer To Pay $35M To Settle Drug Marketing Case

August 6, 2014 4:32 pm | by The Associated Press | News | Comments

Pfizer will pay $35 million to resolve allegations by 42 states that its subsidiary, Wyeth Pharmaceuticals, illegally marketed an organ transplant drug for unapproved uses.             

U.S. Gov't Had Role In Ebola Drug Given To Aid Workers

August 5, 2014 7:46 am | by Marilynn Marchione, AP Chief Medical Writer | News | Comments

Two American aid workers infected with Ebola are getting an experimental drug so novel it has never been tested for safety in humans and was only identified as a potential treatment earlier this year, thanks to a longstanding research program by the U.S. government and the military.

Allergan Sues Valeant

August 5, 2014 7:38 am | by Linda A. Johnson, AP Business Writer | News | Comments

Botox and eye-drug maker Allergan is suing a Canadian drug maker and a hedge fund over their hostile takeover attempt, alleging insider trading and other fraud before their plan became public.           

Advertisement

Experimental Ebola Drug Not Used On U.S. Missionary

August 4, 2014 8:14 am | by Helen Branswell, The Canadian Press | News | Comments

The Canadian company that is developing an experimental Ebola drug says its product was not given to one of two American aid workers infected with the virus.                 

Biotech Drugmaker Amgen Laying Off At Least 2,400

July 29, 2014 11:27 pm | by Linda A. Johnson - AP Business Writer - Associated Press | News | Comments

Biologic drugmaker Amgen said Tuesday that it will lay off 12 to 15 percent of its worldwide workforce and close four sites, even as it reported stellar second-quarter results that ...             

$1,000 Pill Now Treatment Of Choice

July 29, 2014 8:40 am | by Ricardo Alonso-Zaldivar, Associated Press | News | Comments

A $1,000-per-pill drug that insurers are reluctant to pay for has quickly become the treatment of choice for a liver-wasting viral disease that affects more than 3 million Americans.                 

China To Put Glaxo Investigators On Trial In August

July 29, 2014 8:37 am | News | Comments

A Shanghai court says American and British investigators who worked for drug maker GlaxoSmithKline will stand trial Aug. 8 on charges of illegally obtaining information on Chinese citizens.                       

Drug Maker Fights Pediatricians' New Advice

July 28, 2014 10:38 am | by Lindsey Tanner, AP Medical Writer | News | Comments

A costly drug given mostly to premature babies is at the center of a clash between the manufacturer and the nation's leading pediatrician's group, which recommends scaling back use of the medicine.              

Advertisement

U.S. Executions Marked By Challenges, Drug Shortages

July 25, 2014 8:03 am | News | Comments

After more than three decades of using the same three-drug combo to put hundreds of inmates to death with few problems, states have scrambled in recent years to find alternative drugs because of a shortage rooted in European opposition to capital punishment.

FDA Reviewing What Might Become First Biosimilar Drug

July 25, 2014 7:51 am | News | Comments

The Food and Drug Administration is reviewing research data on what could become the first U.S.-approved "biosimilar" drug, a cheaper, sort-of generic version of a biologic drug.                   

Texas Firm Recalls Compounded Drugs

July 24, 2014 7:56 am | News | Comments

The Food and Drug Administration is warning doctors not to use compounded drugs from a Texas specialty pharmacy due to risks of contamination.                     

Inspection Finds Issues At GSK Vaccine Plant

July 23, 2014 10:10 am | by Helen Branswell, The Canadian Press | News | Comments

A recent Health Canada inspection of the country's only flu vaccine production plant identified 10 issues that need to be addressed, a report from the regulatory agency reveals.               

Allergan To Cut 1,500 Jobs

July 21, 2014 10:17 am | by Tom Murphy, AP Business Writer | News | Comments

Botox-maker Allergan says it is cutting about 13 percent of its workforce, or roughly 1,500 employees, as part of a push to become more efficient and productive.                      

AbbVie, Shire Agree On $55B Deal

July 18, 2014 7:58 am | by Tom Murphy, AP Business Writer | News | Comments

AbbVie has reached a roughly $55 billion deal to combine with British counterpart Shire and become the latest U.S. company to seek an overseas haven from corporate income tax rates back home.                 

Novartis, Google To Develop 'Smart' Contact Lens

July 15, 2014 8:56 am | News | Comments

Swiss drug developer Novartis will team with technology giant Google to develop a "smart" contact lens that could improve some eye conditions or help diabetics manage their disease.                       

China Indicts Corporate Investigators Involved In GSK Probe

July 15, 2014 8:25 am | News | Comments

Humphrey and Yu are part of an industry of investigators who help corporate clients screen potential partners and employees or watch for embezzlement and other employee misconduct.                 

Mylan Buying Abbott Business Line In $5.3B Deal

July 14, 2014 8:25 am | News | Comments

The generic drug maker Mylan is buying Abbott Laboratories' generic-drugs business in developed markets for stock valued at about $5.3 billion.                         

Gov. Patrick Signs Compounding Pharmacy Oversight Changes

July 11, 2014 7:46 am | News | Comments

The measure had been in the works for nearly two years, since a nationwide meningitis outbreak linked to the now-closed New England Compounding Center in Framingham. A tainted steroid produced by the company was blamed for 64 deaths and hundreds of illnesses.

FDA Approves First Drug From Anacor Pharma

July 9, 2014 2:32 pm | News | Comments

Shares of Anacor Pharmaceuticals Inc. climbed after federal regulators approved its first drug, the toenail fungus treatment Kerydin, a few weeks ahead of schedule.               

EU Fines Drug Makers $580M

July 9, 2014 8:08 am | News | Comments

The European Union's antitrust body is imposing a fine of $580 million on France's pharmaceutical company Servier and five producers of generic medicines for distorting competition.            

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading